Gaukhar Bakhtiyarova¹*, Remzi Tınazlı² and Mehtap Tınazlı³

¹Near East University, Faculty of Medicine, Department of Internal Medicine, Nicosia, TRNC, Cyprus
²Near East University Hospital, Department of Otorhinolaryngology, Nicosia, TRNC, Cyprus
³Near East University, Faculty of Medicine, Department of Internal Medicine, Nicosia, TRNC, Cyprus

*Corresponding Author: Gaukhar Bakhtiyarova, Near East University, Faculty of Medicine, Department of Internal Medicine, Nicosia, TRNC, Cyprus.

Received: April 17, 2023; Published: May 08, 2023

Abstract

Metabolic syndrome (Met S) is a serious health problem that is becoming increasingly common all over the world. This almost pandemic condition includes a variety of abnormalities such as obesity, hypertension, impaired glucose tolerance, high triglycerides levels, and low high-density lipoprotein (HDL) levels. Although the exact etiopathogenesis is not known, insulin resistance seems to play the most important role. The presence of Met S is important because it is associated with the risk of stroke, heart disease, and the development of diabetes mellitus. In addition to cardiometabolic complications, it is a disorder that can cause multysistemic problems, including hearing loss. There are many studies supporting the relationship between Met S and hearing loss in the literature. The precise mechanism behind this association are not yet fully understood, but it is thought that the metabolic changes (insulin resistance, inflammation, oxidative stress) that occure in Met S may damage the blood vessels and nerves of inner ear, which can lead to hearing loss. In particular, high blood pressure and high blood sugar levels are thought to be major contributors to this process.

Hearing loss is a problem that increases with aging and can develop due to various environmental factors such as noise exposure and infections as well as genetic reasons. It is a common a major problem that the quality of life directly affects negatively.

Treatment for Met S usually involves lifestyle changes, such as increasing physical activity and improving diet, as well as medications to manage the individual risk factors. Diagnosing and managing Met S may therefore be important for preventing or managing hearing loss. The aim of this review is to try to explain the relationship between Met S and hearing loss and to provide detailed literature support. In addition, new treatment approaches targeting risk factors will be mentioned.

 Keywords: Metabolic Syndrome; Hearing Loss; Risk Factors; Therapy

References

1. Yasir HE., et al. “Metabolic syndrome and its association with obesity and lifestyle factors in Sudanese population”. Diabetology and Metabolic Syndrome3 (2016): 128-131.
2. Ebrahimi H., et al. “Metabolic syndrome and its risk factors among middle aged population of Iran, a population based study”. Diabetology and Metabolic Syndrome1 (2016): 19-22.
3. Hughes GB., et al. “Sudden sensorineural hearing loss”. Otolaryngologic Clinics of North America 29 (1996): 393-405.
4. Tabatabaie AM., et al. “Prevalence of metabolic syndrome in adult population in Shiraz, southern Iran”. Diabetes and Metabolic Syndrome: Clinical Research and Reviews3 (2015): S153-156.
5. Sattar N., et al. “Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study”. Circulation 4 (2003): 414-419.
6. Lakka HM., et al. “The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men”. JAMA 21 (2002): 2709-2716.
7. Reaven GM. “Banting lecture 1988. Role of insulin resistance in human disease”. Diabetes12 (1988): 1595-1607.
8. Li X., et al. “Impact of Metabolic Syndrome and It’s Components on Prognosis in Patients With Cardiovascular Diseases: A Meta-Analysis”. Frontiers in Cardiovascular Medicine 8 (2021): 704145.
9. Kahn CR., et al. “Altered adipose tissue and adipocyte function in the pathogenesis of metabolic syndrome”. Journal of Clinical Investigation 129 (2019): 3990-4000.
10. Hu J., et al. “Abdominal Obesity Is More Closely Associated With Diabetic Kidney Disease Than General Obesity”. Diabetes Care 39 (2016): e179-e180.
11. Fan H., et al. “Abdominal obesity is strongly associated with Cardiovascular Disease and its Risk Factors in Elderly and very Elderly Community-dwelling Chinese”. Scientific Report 6 (2016): 21521.
12. Smith U. “Abdominal obesity: A marker of ectopic fat accumulation”. Journal of Clinical Investigation 125 (2016): 1790-1792.
13. Neeland IJ., et al. “Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: A position statement”. Lancet Diabetes Endocrinology 7 (2019): 715-725.
14. Abate N., et al. “Relationship of generalized and regional adiposity to insulin sensitivity in men with NIDDM”. Diabetes 45 (1996): 1684-1693.
15. Scheja L and Heeren J. “The endocrine function of adipose tissues in health and cardiometabolic disease”. Nature Reviews Endocrinology 15 (2019): 507-524.
16. Thomas D and Apovian C. “Macrophage functions in lean and obese adipose tissue”. Metabolism 72 (2017): 120-143.
17. Appari M., et al. “Metabolic Regulation of Adipose Tissue Macrophage Function in Obesity and Diabetes”. Antioxidants and Redox Signaling 29 (2018): 297-312.
18. De Ferranti S., et al. “The perfect storm: Obesity, adipocyte dysfunction, and metabolic consequences”. Clinical Chemistry 54 (2008): 945-955.
19. Aghazadeh-Attari J., et al. “Association between metabolic syndrome and sensorineural hearing loss: a cross-sectional study of 11,114 participants”. Diabetology and Metabolic Syndrome 10 (2017): 459-465.
20. Jung SY., et al. “Association of metabolic syndrome with sudden sensorineural hearing loss”. JAMA Otolaryngology – Head and Neck Surgery4 (2018): 308-314.
21. Lee HY., et al. “Metabolic syndrome is not an independent risk factor for hearing impairment”. Journal of Nutrition Health Aging 8 (2016): 816-824.
22. Chang NC., et al. “The association of insulin resistance and metabolic syndrome with age-related hearing loss”. Journal of Diabetes and Metabolic Disorders 5 (2014): 440.
23. Sun YS., et al. “Components of metabolic syndrome as risk factors for hearing threshold shifts”. PLoS ONE 8 (2015): e0134388
24. Cunningham LL and Tucci DL. “Hearing loss in adults”. The New England Journal of Medicine 377 (2017): 2465-2473.
25. Vos T., et al. “Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013”. Lancet 386 (2015): 743-800.
26. Sun YS., et al. “Components of metabolic syndrome as risk factors for hearing threshold shifts”. PLoS ONE 10 (2015): e0134388.
27. Choi J and Chung WH. “Age-related hearing loss and the effects of hearing aids”. Journal of the Korean Medical Association 54 (2011): 918-924.
28. Ciorba A., et al. “The impact of hearing loss on the quality of life of elderly adults”. Clinical Interventions in Aging 7 (2012): 159-163.
29. Hong JW., et al. “The prevalence and factors associated with hearing impairment in the Korean adults: the 2010-2012 Korea National Health and Nutrition Examination Survey (observational study)”. Medicine (Baltimore) 94 (2015): e61.
30. Sun YS., et al. “Components of metabolic syndrome as risk factors for hearing threshold shifts”. PLoS One 8 (2015): e0134388.
31. Kang SH., et al. “Association between HbA1c level and hearing impairment in a nondiabetic adult population”. Metabolic Syndrome and Related Disorders2 (2016): 129-134.
32. Zhao J., et al. “Association between metabolic syndrome and its components with presbycusis”. Wei Sheng Yan Jiu 4 (2015): 538-42, 548.
33. Chien CY., et al. “Metabolic syndrome increases the risk of sudden sensorineural hearing loss in Taiwan: a case-control study”. Otolaryngology–Head and Neck Surgery1 (2015): 105-111.
34. Lee HY., et al. “Metabolic syndrome is not an independent risk factor for hearing impairment”. Journal of Nutrition and Health Aging8 (2016): 816-824.
35. Aghazadeh-Attari J., et al. “Association between metabolic syndrome and sensorineural hearing loss: a cross-sectional study of 11,114 participants”. Diabetes, Metabolic Syndrome and Obesity 10 (2017): 459-465.
36. Cherian KE., et al. “Endocrine glands and hearing: auditory manifestations of various endocrine and metabolic conditions”. Indian Journal of Endocrinology and Metabolism 3 (2017): 464-469.
37. Anuja Bhargava., et al. “A Clinical Study to Evaluate the Association Between Metabolic Syndrome and Sensorineural Hearing Loss. Original article”. Indian Journal of Otolaryngology and Head and Neck Surgery 3 (2021): 346-350.
38. Srinivas CV., et al. “Clinical study to evaluate the association between sensorineural hearing loss and diabetes mellitus in poorly controlled patients whose HbA1c”. Indian Journal of Otolaryngology and Head and Neck Surgery 68.2 (2016): 191-195.
39. Dadhich S., et al. “A prospective, observational study of incidence of sensory neural hearing loss in diabetes mellitus patients”. Indian Journal of Otology 24 (2018): 80-82.
40. Parmar SM., et al. “Evaluation of effects of diabetes mellitus type 2 and hyperlipidemia on hearing”. Indian Journal of Otology 23 (2017): 155-161
41. Swaminathan AL., et al. “Evaluation of the auditory effects of hyperlipidaemia and diabetes mellitus by using audiometry”. Journal of Clinical and Diagnostic Research8 (2011): 1528-1532
42. Alessandra G., et al. “Diabetes mellitus and sensorineural hearing loss:is there an association? Baseline of the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). Clinical Science”. CLINICS1 (2017): 5-10.
43. , et al. “The influence of metabolic syndrome on age-related hearing loss from the perspective of mitochondrial dysfunction”. Frontiers in Aging Neuroscience 14 (2016): 930105.
44. Kim S., et al. “Age-related hearing loss in the Korea National Health and Nutrition Examination Survey”. PLoS One 15 (2020a): e0243001.
45. Hlologelo Ramatsoma* and Sean Mark Patrick. “Hypertension Associated With Hearing Loss and Tinnitus Among Hypertensive Adults at a Tertiary Hospital in South Africa”. Frontiers in Neurology 13 (2022): 857600.
46. Hye Yeong Oh and JungEunYoo. “The Association between Duration of Noise Exposure in the Workplace and Glucose Metabolism Status: Evidence from the Korea National Health and Nutrition Examination Survey”. Original Article”. Korean Journal of Family Medicine 43 (2022): 396-402.
47. Federico Maria Gioacchini Davide Pisan., et al. “Diabetes Mellitus and Hearing Loss: A Complex Relationship. Review”. Medicina 59 (2023): 269.
48. Jerremy Chee., et al. “Diabetes is a risk factor for hearing loss in older adults: Results of community”. Clinical Otolaryngology1 (2022): İ-İİİ, 1-253.
49. Grundy SM., et al. “National Heart, Lung, and Blood Institute; American College of Cardiology Foundation; American Heart Association. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines”. Circulation2 (2004): 227-239.
50. Kepekçi AH and Köker Y. “Results of the survey carried out with ENT specialists and residents regarding stem cell transplantation and its use in sensorineural hearing loss”. Journal of Contemporary Medicine 4 (2018): 339-344.

Citation

Citation: Gaukhar Bakhtiyarova., et al. “Metabolic Syndrome and its Relationship with Hearing Loss: Review of Literature”.Acta Scientific Medical Sciences 7.6 (2023): 19-25.

Copyright

Copyright: © 2023 Gaukhar Bakhtiyarova., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.